Cargando…

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1

Disruption of endothelial monolayer integrity is the primary instigating factor for many cardiovascular diseases. High density lipoprotein (HDL) oxidized by heme enzyme myeloperoxidase (MPO) is dysfunctional in promoting endothelial repair. Apolipoprotein A-1 mimetic 4F with its pleiotropic benefits...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Dan, Zhao, Mingming, Wu, Congying, Zhang, Wenjing, Niu, Chenguang, Yu, Baoqi, Jin, Jingru, Ji, Liang, Willard, Belinda, Mathew, Anna V., Chen, Y. Eugene, Pennathur, Subramaniam, Yin, Huiyong, He, Yuan, Pan, Bing, Zheng, Lemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975068/ https://www.ncbi.nlm.nih.gov/pubmed/29277016 http://dx.doi.org/10.1016/j.redox.2017.11.027

Ejemplares similares

Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression
por: Pan, Bing, et al.
Publicado: (2012)

Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis
por: Pan, Bing, et al.
Publicado: (2012)

HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
por: Li, Yufeng, et al.
Publicado: (2016)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
por: Su, Feng, et al.
Publicado: (2020)

Altered HDL proteome predicts incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2021)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

The reorganization of microfilaments, centrosomes, and microtubules during in vitro small wound reendothelialization
Publicado: (1988)

AIM2 Stimulation Impairs Reendothelialization and Promotes the Development of Atherosclerosis in Mice
por: Lüsebrink, Enzo, et al.
Publicado: (2020)

Neurotrophin-3 accelerates reendothelialization through inducing EPC mobilization and homing
por: Chen, Yan, et al.
Publicado: (2020)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
por: Mathew, Anna V., et al.
Publicado: (2019)

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
por: Di Bartolo, Belinda A, et al.
Publicado: (2011)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

The apolipoprotein receptor LRP3 compromises APP levels
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2021)

HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
por: Zhang, Hang, et al.
Publicado: (2023)

Accelerated Reendothelialization, Increased Neovascularization and Erythrocyte Extravasation after Arterial Injury in BAMBI(−/−) Mice
por: Guillot, Nicolas, et al.
Publicado: (2013)

Dynamic Contact Angle Analysis of Protein Adsorption on Polysaccharide Multilayer's Films for Biomaterial Reendothelialization
por: Benni, Safiya, et al.
Publicado: (2014)

Delayed reendothelialization with rapamycin is rescued by the addition of nicorandil in balloon-injured rat carotid arteries
por: Zhang, Ying Qian, et al.
Publicado: (2016)

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Brodeur, Mathieu R., et al.
Publicado: (2022)

The apolipoprotein A‐I mimetic peptide, D‐4F, restrains neointimal formation through heme oxygenase‐1 up‐regulation
por: Liu, Donghui, et al.
Publicado: (2017)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

Apolipoprotein E4 genotype compromises brain exosome production
por: Peng, Katherine Y, et al.
Publicado: (2019)

Advanced oxidation protein products are antagonists of the HDL receptor SR-BI
por: Marsche, Gunther, et al.
Publicado: (2009)

Bimodal Imaging‐Visible Nanomedicine Integrating CXCR4 and VEGFa Genes Directs Synergistic Reendothelialization of Endothelial Progenitor Cells
por: Yu, Bingbo, et al.
Publicado: (2020)

Xinkeshu Improves Endothelial Function and Augments Reendothelialization Capacity in Coronary Artery Disease with Anxiety/Depression
por: Sun, Jiapan, et al.
Publicado: (2021)

Effect of different decellularization protocols on reendothelialization with human cells for a perfused renal bioscaffold of the rat
por: Sauter, Johannes, et al.
Publicado: (2023)

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
por: Karalis, I., et al.
Publicado: (2018)

Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic Peptide
por: Dempsey, Michael P., et al.
Publicado: (2023)

Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial
por: Dunbar, Richard L., et al.
Publicado: (2017)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

ATP Synthase β-Chain Overexpression in SR-BI Knockout Mice Increases HDL Uptake and Reduces Plasma HDL Level
por: Song, Kexiu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dhel01kpenrg3fi7p6njh7a4kt